L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
Results of observational studies with the use of LIPIKAR BAUME AP+M:
Pain sensations & quality of life
- May. 2022
- Supported by
Pruritus, tingling, pain and burning sensations can be a real burden in everyday life.
In fact, 30% of the French population complains of an unpleasant skin sensation1 at least once a day:
- Itching: 32%
- Tingling: 18.9%
- Burning sensations: 5.6%
La Roche-Posay is committed to improving skin health and quality of life. That's why they organized observational studies to better understand patients suffering from atopic-prone and dry skin, in order to soothe even pain sensations.
1034 subjects with atopic-prone skin were included in a prospective, non-interventional, observational assessment in routine care. An initial questionnaire was completed on the day of inclusion, and a second questionnaire after 7 days of using LIPIKAR AP+M.
After 7 days of using LIPIKAR BAUME AP+M, unpleasant sensations were reduced at least by half.
Subjects felt that:
- Itching sensations had improved by 87%
- Tingling sensations by 81%
- Pain sensations by 77%
- Burning sensations by 79%
More than 8 out of 10 subjects saw their condition improve after only one week.
Two other studies were conducted to evaluate LIPIKAR BAUME AP+M’s tolerance and effect on reducing signs and improving subjects’ quality of life:
One study was carried out on 1161 babies and children (B&C), with the results compiled after one month.
The other was carried out on 1339 adults (A) aged 16 and over, with the results compiled after two months.
As expected, they respectively reveal:
- A 75% reduction on the impact on sleep quality after one month of use (B&C), and an 86% drop after two months of use (A);
- A significant improvement on skin discomfort, with pain sensations reduced by 69% after one month of use (B&C), and by 87% after two months of use (A);
- A 74% reduction on the impact on quality of life after one month of use (B&C), and an 82% drop after two months of use (A).
Therefore, LIPIKAR BAUME AP+M is a highly effective emollient that improves the everyday life of atopic-prone skin patients, including babies, children and adults. Thanks to its triple action, LIPIKAR BAUME AP+M soothes patients’ signs and sensations of pain, by:
- Rebalancing the skin microbiome,
- Reinforcing the skin barrier,
- Soothing inflammation.
Bibliography
- Misery L, Ezzedine K, Corgibet F, Dupin N, Sei JF, Philippe C, Joly P, Taieb C, Richard MA. Sex- and age-adjusted prevalence estimates of skin types and unpleasant skin sensations and their consequences on quality of life: results of a study of a large representative sample of the French population. Br J Dermatol. 2019 Jun;180(6):1549-1550. doi: 10.1111/bjd.17467. Epub 2019 Feb 13. PMID: 30500070.